Krebs Biochemicals and Industries Ltd share price is currently ₹53.08, down by - ₹0.17 (0.32%) from its previous closing price of ₹53.25. The share price has declined -3.77% over the past month and declined -32.81% over the past year. The stock's 52-week low and high are ₹37.74 and ₹82.08, respectively. Krebs Biochemicals and Industries Ltd has a market capitalisation of ₹ 120.00 Cr. The share price was last updated on 25 Aug 2026, 03:22 PM IST.

Updated: 25 Aug 2026, 03:22:44 pm IST

Corporate Actions will be available shortly.
Mutual Fund Ownership will be available shortly.Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company's pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Today's market leaders and laggards
Genesys International Corporation Ltd
GENESYS
₹212.29
+37.16 (21.22%)
Fertilisers And Chemicals Travancore Ltd
FACT
₹862.94
+85.12 (10.94%)
Sigachi Industries Ltd
SIGACHI
₹33.29
+3.26 (10.86%)
Genus Paper & Boards Ltd
GENUSPAPER
₹12.00
+1.12 (10.29%)
Federal-Mogul Goetze (India) Ltd
FMGOETZE
₹529.51
+49.23 (10.25%)